• EZ Cap™ Cas9 mRNA (m1Ψ) Workflow Guide

  2026-08-12

  Build a controlled CRISPR-Cas9 mRNA workflow around Cap1 capping, m1Ψ modification, poly(A)-supported translation, and careful dose timing. This guide also translates evidence on Cas9 mRNA nuclear export into practical assays for improving editing specificity in mammalian cells.

• CXCR4 Theranostics in Lymphoma: Evidence and Limits

  2026-08-12

  This 2026 review presents CXCR4 as a bridge between molecular imaging and targeted treatment in lymphoma, linking receptor biology with PET, SPECT, radioligand therapy, inhibitors, and antibody-based strategies. Its practical value lies in showing how CXCR4 expression may support disease characterization and treatment selection while also emphasizing physiological uptake, CXCR7 compensation, and the need for better patient stratification.

• Loop Extrusion Rate Tunes Genome Folding

  2026-08-11

  The reference preprint identifies cohesin loop-extrusion rate as a tunable parameter controlled by NIPBL and PDS5 dosage. Its findings suggest that altered extrusion dynamics can be buffered to preserve chromosome structure and transcription, but that this buffering also creates vulnerability to dosage changes relevant to cohesinopathies.

• GS-441524 Prodrug Assay Workflow Guide

  2026-08-11

  Build more informative antiviral and pharmacokinetic assays by tracking both GS-441524 and its prodrug-derived metabolite across biological matrices. This practical guide combines material handling, LC–MS/MS workflow design, conversion controls, and troubleshooting for research teams studying SARS-CoV-2-related mechanisms.

• AMPK–SQSTM1 Feedback Under Metabolic Stress

  2026-08-10

  The 2024 Autophagy study identifies a double-positive feedback loop in which AMPK and SQSTM1/p62 reinforce one another during metabolic stress. This circuit simultaneously promotes KEAP1 degradation, NFE2L2/NRF2 activation, and lysosomal AMPK signaling, clarifying how cancer cells coordinate energy and antioxidant defenses.

• Berberine, RXRα/PPARγ, and SASP in Atherosclerosis

  2026-08-09

  The reference study identifies an RXRα/PPARγ/NEDD4 pathway through which berberine suppresses SASP-related inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of transcriptomic profiling, cell models, and macrophage-focused RXRα knockdown provides a framework for testing receptor-dependent mechanisms in vascular aging.

• Thrombin at the Translational Nexus

  2026-08-08

  A mechanistic and strategic guide to using thrombin biology, protease-selectivity principles, and the Coagulation Factor II B Chain Fragment in translational coagulation and vascular research.

• Corneal Nanoparticle Uptake: Size and Surface Chemistry

  2026-08-07

  Azadi and David systematically examined how nanoparticle size and surface chemistry shape interactions with human corneal epithelial cells using engineered PLGA nanoparticles and an in vitro mucosal model. Their results identify energy-dependent endocytosis, particularly macropinocytosis and caveolae-mediated uptake, as a practical design target for improving topical ocular delivery while preserving acceptable short-term cell viability.

• Nav1.5 Ser571 Phosphorylation Drives Age-Linked Cardiac Dysf

  2026-08-07

  This study demonstrates that phosphorylation of the cardiac sodium channel Nav1.5 at Ser571 enhances late sodium current, leading to delayed ventricular repolarization and diastolic dysfunction in aging hearts. The findings establish a mechanistic link between molecular channel modification and age-related cardiac myopathy, guiding targeted arrhythmia prevention strategies.

• Sumatriptan’s Emerging Anti-Inflammatory Roles: Systematic R

  2026-08-06

  This systematic review critically re-examines sumatriptan, a well-known antimigraine agent, revealing its significant anti-inflammatory properties through modulation of cytokines, nitric oxide pathways, and neuropeptide release. These findings open new directions for translational research in inflammation, with implications for protocol design and candidate drug benchmarking.

• CK2 Inhibition in Cancer and Virology: Strategic Insights fo

  2026-08-06

  This article provides a comprehensive, mechanistically grounded perspective on CK2 inhibition in both cancer and emerging antiviral applications. Focusing on CX-4945 (Silmitasertib) from APExBIO, it bridges oncology and virology, detailing the underlying biology, experimental protocols, and strategic guidance for translational researchers aiming to leverage CK2α as a therapeutic target.

• Caspase-3–NDUFS1 Axis Drives Mitochondrial ROS in Trichothec

  2026-08-05

  This study uncovers how trichothecene mycotoxins such as DON and T-2 toxin trigger reactive oxygen species (ROS) accumulation and mitochondrial dysfunction in liver via caspase-3-mediated cleavage of NDUFS1, a complex I subunit. The findings clarify molecular mechanisms of toxin-induced oxidative stress, highlighting both mitochondrial and ER sources of ROS and revealing new therapeutic targets for mycotoxin-induced liver injury.

• GS-441524 (SKU B8461): Data-Driven Solutions for Antiviral A

  2026-08-05

  This article delivers a scenario-driven, evidence-based guide to using GS-441524 (SKU B8461) for robust antiviral research. Drawing on recent LC–MS/MS findings and validated best practices, we address common assay challenges and highlight how APExBIO’s GS-441524 offers high purity, reliability, and practical workflow advantages for cell viability and pharmacokinetic studies.

• GS967: Advanced Cardiac Late Sodium Current Inhibitor Workfl

  2026-08-04

  GS967 delivers precision inhibition of the late sodium current in cardiac research, enabling robust arrhythmia prevention studies and modeling of age-related cardiac dysfunction. This guide translates recent mechanistic insights into optimized experimental protocols and troubleshooting strategies for in vitro and ex vivo models.

• CBD Modulates Orofacial Inflammatory Pain via Endocannabinoi

  2026-08-04

  The referenced study demonstrates that cannabidiol (CBD) alleviates both sensory and affective dimensions of orofacial inflammatory pain in mice, acting through coordinated modulation of peripheral and central endocannabinoid signaling as well as serotonergic pathways. These findings highlight the potential for CBD as a comprehensive therapeutic strategy in pain states with prominent emotional comorbidities, providing mechanistic insight for translational research.

11264 records 1/751 page Next 12345 下5页 Last page